发明名称 |
SYNERGISM BETWEEN THYMIDINE KINASE GENE THERAPY AND TOPOISOMERASE I AND TOPOISOMERASE II INHIBITORS |
摘要 |
The invention describes a method in which adenovirus mediated thymidine kinase gene therapy enhances the sensitivity of ovarian cancer cells to topoisomerase inhibitors chemotherapy. This combination demonstrates synergistic properties. The combination is most effective when the gene therapy treatment is administered first, followed by topoisomerase inhibitor chemotherapy.
|
申请公布号 |
WO9938992(A1) |
申请公布日期 |
1999.08.05 |
申请号 |
WO1999US02302 |
申请日期 |
1999.02.03 |
申请人 |
BAYLOR COLLEGE OF MEDICINE |
发明人 |
KIEBACK, DIRK, G.;TONG, XIAO-WEN |
分类号 |
A61K38/45;A61K48/00;(IPC1-7):C12P7/24;C12P7/26;C12P15/00;A01N63/00;C12C1/00 |
主分类号 |
A61K38/45 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|